CD8A and neoplasm: DCs, as pivotal bridges between innate and adaptive immunity, possess exceptional capabilities in antigen uptake, processing, and cross-presentation, thereby effectively inducing activation and expansion of CD8+ T cells to elicit CTL-mediated anti-tumor effects (My et al., 2024).